Business Context and Reporting Period
Company: Nature's Sunshine Products, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 1995
Business Overview: The Company manufactures and distributes natural health and nutritional products through a direct sales marketing program utilizing an independent sales force of Managers and Distributors. Operations are conducted domestically and internationally, with significant recent expansion into Japan and Brazil.
Key Financial Metrics
| Metric | Q1 1995 | Q1 1994 |
|---|---|---|
| Sales Revenue | $47,061,760 | $37,336,982 |
| Net Income | $2,013,887 | $1,701,118 |
| Operating Income | $2,987,050 | $3,067,201 |
| Net Cash from Operations | $5,226,039 | $5,724,153 |
| Cash and Equivalents (End of Period) | $13,831,868 | $12,708,253 |
| Short-Term Debt | $1,675,932 | $1,533,042 |
| Current Ratio | 1.82 | 2.06 |
| Earnings Per Share | $0.16 | $0.14 |
Note: Current Ratio calculated as Total Current Assets divided by Total Current Liabilities.
Material Changes vs. Prior Period
- Revenue Growth: Sales revenue increased 26.05% year-over-year, driven by a 47% increase in international sales and a 18% increase in domestic sales. The independent sales force grew significantly, with Managers increasing from 7,367 to 10,616 and Distributors from 160,044 to 262,453.
- Profitability: While Net Income increased 18.39%, Operating Income decreased slightly by 2.61% due to higher operating expenses relative to sales.
- Expense Structure:
- Volume Incentives: Increased 23.00% in absolute terms but decreased slightly as a percentage of sales (from 47.46% to 46.31%) due to lower incentive rates in new markets (Japan, Brazil).
- SG&A Expenses: Increased 37.34% year-over-year, rising from 25.45% to 27.73% of sales, primarily due to $2.1 million in incremental costs for new international operations.
- Cost of Goods Sold (COGS): Increased 30.94% year-over-year, rising from 18.88% to 19.61% of sales, largely attributed to the devaluation of the Mexican Peso.
- Balance Sheet: Accrued volume incentives increased by approximately $1.9 million, and accrued liabilities increased by $1.7 million, reflecting higher sales volumes and related incentive accruals.
Outlook, Risks, and Management Commentary
- Guidance: Management expects volume incentives and SG&A expenses to decrease slightly as a percentage of sales for the remainder of 1995 as sales in Japan and Brazil mature. COGS is also expected to decrease slightly as a percentage of sales.
- Liquidity and Capital: Cash and cash equivalents increased by $2.6 million. The Company utilized $1.1 million to purchase treasury stock and $0.6 million for dividends. Management believes future working capital needs can be internally funded but may seek long-term financing for potential domestic facility expansions.
- Risks and Contingencies:
- Foreign Exchange: The devaluation of the Mexican Peso caused a 38% sales decrease in Mexico and increased COGS. Foreign exchange losses were recorded ($127,018).
- Start-up Costs: New operations in Japan and Brazil are currently operating at a loss or low margin, contributing to higher SG&A ratios.
- Dividends: The Company declared a quarterly cash dividend of $0.05 per share, marking the 27th consecutive quarterly dividend.
Investor Verification Checklist
- International Exposure: Verify the sustainability of sales growth in Japan and Brazil versus the volatility in Mexico due to currency devaluation.
- Margin Compression: Monitor if SG&A and COGS percentages of sales decline in subsequent quarters as projected by management.
- Debt and Liquidity: Confirm the stability of short-term debt levels and the adequacy of cash flow to fund the announced stock buyback program and potential facility expansions.
- Sales Force Retention: Assess the correlation between the rapid growth in the independent sales force and the retention of volume incentive payouts.